Literature DB >> 8633097

Normal human serum contains a natural IgM antibody cytotoxic for human neuroblastoma cells.

M W Ollert1, K David, C Schmitt, A Hauenschild, R Bredehorst, R Erttmann, C W Vogel.   

Abstract

Neuroblastoma (NB) is characterized by the second highest spontaneous regression of any human malignant disorder, a phenomenon that remains to be elucidated. In this study, a survey of 94 normal human adult sera revealed a considerable natural humoral cytotoxicity against human NB cell lines in approximately one-third of the tested sera of both genders. Specific cell killing by these sera was in the range of 40% to 95%. Serum cytotoxicity was dependent on an intact classical pathway of complement. By several lines of evidence, IgM antibodies were identified as the cytotoxic factor in the sera. Further analyses revealed that a 260-kDa protein was recognized by natural IgM of cytotoxic sera in Western blots of NB cell extracts. The antigen was expressed on the surface of seven human NB cell lines but not on human melanoma or other control tumor cell lines derived from kidney, pancreas, colon, bone, skeletal muscle, lymphatic system, and bone marrow. Furthermore, no reactivity was observed with normal human fibroblasts, melanocytes, and epidermal keratinocytes. The antigen was expressed in vivo as detected by immunohistochemistry in both the tumor of a NB patient and NB tumors established in nude rats from human NB cell lines. Most interestingly, the IgM anti-NB antibody was absent from the sera of 11 human NB patients with active disease. The anti-NB IgM also could not be detected in tumor tissue obtained from a NB patient. Collectively, our data suggest the existence of a natural humoral immunological tumor defense mechanism, which could account for the in vivo phenomenon of spontaneous NB tumor regression.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8633097      PMCID: PMC39567          DOI: 10.1073/pnas.93.9.4498

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  IN SITU NEUROBLASTOMAS: A CONTRIBUTION TO THE NATURAL HISTORY OF NEURAL CREST TUMORS.

Authors:  J B BECKWITH; E V PERRIN
Journal:  Am J Pathol       Date:  1963-12       Impact factor: 4.307

2.  Characterization of the WIDR: a human colon carcinoma cell line.

Authors:  P Noguchi; R Wallace; J Johnson; E M Earley; S O'Brien; S Ferrone; M A Pellegrino; J Milstien; C Needy; W Browne; J Petricciani
Journal:  In Vitro       Date:  1979-06

3.  Demonstration of cell-bound and humoral immunity against neuroblastoma cells.

Authors:  I E Hellström; K E Hellström; G E Pierce; A H Bill
Journal:  Proc Natl Acad Sci U S A       Date:  1968-08       Impact factor: 11.205

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Cobra venom factor: improved method for purification and biochemical characterization.

Authors:  C W Vogel; H J Müller-Eberhard
Journal:  J Immunol Methods       Date:  1984-10-12       Impact factor: 2.303

6.  Monoclonal antibodies against epitopes on ganglioside GD2 and its lactones. Markers for gliomas and neuroblastomas.

Authors:  K Bosslet; H D Mennel; F Rodden; B L Bauer; F Wagner; A Altmannsberger; H H Sedlacek; H Wiegandt
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

7.  Monoclonal antibodies to a glycolipid antigen on human neuroblastoma cells.

Authors:  N K Cheung; U M Saarinen; J E Neely; B Landmeier; D Donovan; P F Coccia
Journal:  Cancer Res       Date:  1985-06       Impact factor: 12.701

8.  Monoclonal antibody-directed effector cells selectively lyse human melanoma cells in vitro and in vivo.

Authors:  G Schulz; T F Bumol; R A Reisfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

9.  Spontaneous tumor regression: possible relationship to in vitro parameters of tumor immunity.

Authors:  K E Hellström; I Hellström
Journal:  Natl Cancer Inst Monogr       Date:  1976-11

10.  Cell surface antigens of human renal cancer defined by autologous typing.

Authors:  R Ueda; H Shiku; M Pfreundschuh; T Takahashi; L T Li; W F Whitmore; H F Oettgen; L J Old
Journal:  J Exp Med       Date:  1979-09-19       Impact factor: 14.307

View more
  7 in total

Review 1.  Monoclonal antibody-based therapy for neuroblastoma.

Authors:  N K Cheung
Journal:  Curr Oncol Rep       Date:  2000-11       Impact factor: 5.075

2.  Day care, childhood infections, and risk of neuroblastoma.

Authors:  Florence Menegaux; Andrew F Olshan; Joseph P Neglia; Brad H Pollock; Melissa L Bondy
Journal:  Am J Epidemiol       Date:  2004-05-01       Impact factor: 4.897

Review 3.  Neuroblastoma: developmental biology, cancer genomics and immunotherapy.

Authors:  Nai-Kong V Cheung; Michael A Dyer
Journal:  Nat Rev Cancer       Date:  2013-06       Impact factor: 60.716

4.  High level expression of functional human IgMs in human PER.C6 cells.

Authors:  Anna Tchoudakova; Frank Hensel; Alec Murillo; Bernie Eng; Marketa Foley; Lakee Smith; Frank Schoenen; Antonia Hildebrand; Arndt-René Kelter; Leodevico L Ilag; H Peter Vollmers; Stephanie Brandlein; Jane McIninch; John Chon; Gene Lee; Marco Cacciuttolo
Journal:  MAbs       Date:  2009-03-24       Impact factor: 5.857

5.  A novel IgM-H-ficolin complement pathway to attack allogenic cancer cells in vitro.

Authors:  Xiaoying Lei; Chaoxu Liu; Kazem Azadzoi; Cuiling Li; Fan Lu; An Xiang; Jianbin Sun; Yanhai Guo; Qingchuan Zhao; Zhen Yan; Jinghua Yang
Journal:  Sci Rep       Date:  2015-01-16       Impact factor: 4.379

6.  L2pB1 Cells Contribute to Tumor Growth Inhibition.

Authors:  Varuna Shibad; Ali Bootwala; Changchuin Mao; Hanna Bader; Hung Vo; Esther Landesman-Bollag; Conrad Guo; Angel Rubio; Richard Near; Wenda Gao; Sreekar Challa; Vennela Chukka; Jeffrey Gao; Avery Kelly; Tamar Landesman; Tyler VanHelene; Xuemei Zhong
Journal:  Front Immunol       Date:  2021-09-23       Impact factor: 7.561

7.  Temporal clustering of neuroblastic tumours in children and young adults from Northern England.

Authors:  Colin R Muirhead; Deborah A Tweddle; Nermine O Basta; Richard J Q McNally
Journal:  Environ Health       Date:  2015-09-04       Impact factor: 5.984

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.